Insulet Corporation

Insulet Corporation Stock

22.91P/E
€8.68BMarket capitalisation
US$6.12Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Insulet Corporation is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Insulet Corporation stock.

Market capitalisation
€8.68B
P/E
22.91
P/B
7.62
P/S
3.08
P/CF
16.40
Issued shares 69M Units

Return

Here you can see the performance of the Insulet Corporation stock.

PeriodPerfor­mance
1 Week-6.88 %
1 Month-0.16 %
3 Months-2.93 %
6 Months-53.69 %
1 Year-56.47 %
YTD-49.11 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Insulet Corporation share.

DateRatio
No data available.

Which ETF contains the Insulet Corporation stock?

The Insulet Corporation stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Insulet Corporation has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Insulet Corporation stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.